Skip to main content

5 Result(s)

within Klaus G. Parhofer Remove this filter Internal Medicine Remove this filter

and

  1. Article

    Open Access

    PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

    Several lipid guidelines recommend that proprotein convertase subtilisin/kexin type 9 inhibitors should be considered for patients with atherosclerotic cardiovascular disease who are inadequately treated with ...

    Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann… in Drugs - Real World Outcomes (2019)

    Download PDF (846 KB) View Article

  2. No Access

    Article

    Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus

    Klaus G. Parhofer, Andreas L. Birkenfeld, Wilhelm Krone, Michael Lehrke… in Der Diabetologe (2019)

  3. No Access

    Article

    Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics

    Whether whole-body MRI can predict occurrence of recurrent events in patients with diabetes mellitus.

    Robert C. Bertheau, Fabian Bamberg, Elena Lochner… in European Radiology (2016)

  4. No Access

    Article

    Stärken und Grenzen randomisierter Studien zur Lipidtherapie

    Zunehmend enden Interventionsstudien zu wesentlichen therapeutischen Fragestellungen mit einem nicht signifikanten Ergebnis für den primären Endpunkt. Das prägt auch das Bild der randomisierten Studien im Bere...

    Eberhard Windler, Prof. Dr. med. Gerald Klose, Klaus G. Parhofer… in CardioVasc (2014)

  5. No Access

    Article

    New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk

    After the publication of the new guidelines of the European Society of Cardiology and the European Atherosclerosis Society for the prevention and treatment of dyslipidemias (Eur Heart J 32:1769–1818, 2011; Eur...

    Gerald Klose, Frank Ulrich Beil, Hans Dieplinger… in Wiener klinische Wochenschrift (2014)